Market revenue in 2022 | USD 68.6 million |
Market revenue in 2030 | USD 759.5 million |
Growth rate | 35.1% (CAGR from 2022 to 2030) |
Largest segment | Deep learning |
Fastest growing segment | Natural language processing |
Historical data | 2017 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Deep Learning, Querying Method, Natural language processing, Context aware processing |
Key market players worldwide | BioXcel Therapeutics Inc, Sanofi SA, NVIDIA Corp, Alphabet Inc Class A, International Business Machines Corp, Microsoft Corp, Intel Corp, AstraZeneca PLC, GE HealthCare Technologies Inc Common Stock, Enlitic |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in precision medicine market will help companies and investors design strategic landscapes.
Deep learning was the largest segment with a revenue share of 33.82% in 2022. Horizon Databook has segmented the Canada artificial intelligence in precision medicine market based on deep learning, querying method, natural language processing, context aware processing covering the revenue growth of each sub-segment from 2017 to 2030.
The market growth in Canada is driven by rising demand for precision medication and R&D expenditure. Collaborations among significant companies are fostering expansion. For instance, Atom wise and Sanofi agreed to a 20-million-dollar contract in August 2022. Sanofi would use Atom wise's Atom Net platform for computational discovery and research on up to five therapeutic objectives.
Through fast, AI-powered search operations of the company's proprietary library of over 3 trillion synthesized complexes, the platform incorporates a deep learning-based module for structure-based development of pharmaceuticals. In November 2021, TD Bank Group donated USD 1 million to Sunnybrook to help create an innovative new AI research center.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada artificial intelligence in precision medicine market , including forecasts for subscribers. This country databook contains high-level insights into Canada artificial intelligence in precision medicine market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account